ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 学内発行雑誌
  2. The Showa University journal of medical sciences
  3. Vol.27(2015)
  4. No.1

Usefulness of Continuous Regional Arterial Infusion with Doripenem and Protease Inhibitors for Severe Acute Pancreatitis

https://showa.repo.nii.ac.jp/records/591
https://showa.repo.nii.ac.jp/records/591
13d96599-630e-48b6-9c5c-801452162312
名前 / ファイル ライセンス アクション
S27_29.pdf S27_29.pdf (140.6 kB)
Item type 学内発行雑誌 / Departmental Bulletin Paper(1)
公開日 2018-10-16
タイトル
タイトル Usefulness of Continuous Regional Arterial Infusion with Doripenem and Protease Inhibitors for Severe Acute Pancreatitis
言語 en
言語
言語 eng
資源タイプ
資源タイプ departmental bulletin paper
著者 YAMAMIYA, Akira

× YAMAMIYA, Akira

YAMAMIYA, Akira

Search repository
KITAMURA, Katsuya

× KITAMURA, Katsuya

KITAMURA, Katsuya

Search repository
ISHII, Yu

× ISHII, Yu

ISHII, Yu

Search repository
SATO, Yoshiki

× SATO, Yoshiki

SATO, Yoshiki

Search repository
IWATA, Tomoyuki

× IWATA, Tomoyuki

IWATA, Tomoyuki

Search repository
NOMOTO, Tomohiro

× NOMOTO, Tomohiro

NOMOTO, Tomohiro

Search repository
HONMA, Tadashi

× HONMA, Tadashi

HONMA, Tadashi

Search repository
YOSHIDA, Hitoshi

× YOSHIDA, Hitoshi

YOSHIDA, Hitoshi

Search repository
書誌情報 The Showa University journal of medical sciences

巻 27, 号 1, p. 29-37, 発行日 2015-03
抄録
内容記述タイプ Abstract
内容記述 Doripenem (DRPM) is a relatively new drug belonging to the carbapenem antibiotic group. We hypothesized that the pharmacological characteristics of DRPM could make it useful in the treatment of severe acute pancreatitis (SAP). We investigated the usefulness of continuous regional arterial infusion (CRAI) with DRPM and protease inhibitors for SAP. Two hundred and forty-two patients with SAP were admitted to Showa University Hospital between November 2002 and June 2013. Of these, 53 patients were treated with CRAI with carbapenem antibiotics and nafamostat mesilate (NM), a serine protease inhibitor, via the celiac and superior mesenteric arteries. Clinical outcomes were evaluated retrospectively in 34 patients treated with DRPM and 19 patients undergoing non-DRPM therapy (meropenem n=11, imipenem n=6; biapenem n=2). The median time to commencement of oral intake was significantly shorter in the DRPM than non-DRPM group (9 vs 14 hospital days, respectively; P<0.01). In addition, the rate of walled-off necrosis in the DRPM group tended to be lower than in the non-DRPM group (37.5 vs 64.7%, respectively, P=0.069). The results of the present study suggest that CRAI with DRPM and NM for SAP could have equivalent therapeutic effects to CRAI with other carbapenem antibiotics and NM.
DOI
関連タイプ isIdenticalTo
関連識別子 10.15369/sujms.27.29
出版者
出版者 Showa University Society
ISSN
収録物識別子タイプ ISSN
収録物識別子 0915-6380
出版タイプ
出版タイプ VoR
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 12:41:39.387521
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3